Clinical pharmacology is critical in drug development. This presentation introduces the current status of its application in China, and then presents a PK/PD model for proton-pump inhibitor (PPI) drugs. This mechanism-based model is established using ilaprazole as a case drug in which food effect and circadian rhythm are taken into account, and it provides a potential strategy to accelerate the development of novel PPIs.